Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome. [electronic resource]
Producer: 20160623Description: 1761-9 p. digitalISSN:- 1523-6536
- Adult
- Aged
- Allografts
- Antimetabolites, Antineoplastic -- adverse effects
- Azacitidine -- adverse effects
- Combined Modality Therapy
- Decitabine
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Gastrointestinal Diseases -- chemically induced
- Graft vs Host Disease -- etiology
- Hematologic Diseases -- chemically induced
- Hematopoietic Stem Cell Transplantation
- Humans
- Infusions, Intravenous
- Leukemia, Myeloid, Acute -- drug therapy
- Maintenance Chemotherapy -- methods
- Male
- Maximum Tolerated Dose
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Prospective Studies
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.